Markku N.
- Country
- Finland
- Department
- Terveystalo Ruoholahti Helsinki
Research Overview
Data & Insights
Has run more than one trial at 0 of 2 partner sites.
Specializations
Celiac Disease
Investigator focuses on immune‑mediated gastrointestinal disorder characterized by gluten sensitivity.
- Gluten‑induced enteropathy
- Autoimmune response modulation
- Biomarker identification
Therapeutic development aims to restore intestinal integrity and improve quality of life.
Migraine
Research addresses episodic and chronic migraine with emphasis on preventive interventions for pediatric populations.
- Calcitonin gene‑related peptide antagonism
- Subcutaneous delivery systems
- Pediatric migraine prophylaxis
Efforts target reduction of attack frequency and mitigation of disability.
Major Depressive Disorder
Work targets major depressive disorder featuring moderate‑to‑severe anhedonia and treatment‑resistant profiles.
- Adjunctive antidepressant strategies
- Anhedonia assessment tools
- Neurotransmitter modulation
Goal is to alleviate depressive symptoms and restore motivational capacity.
Alzheimer’s Disease
Investigations involve mild to moderate Alzheimer’s disease focusing on cognitive impairment and functional decline.
- Cognitive enhancement agents
- Global functioning measures
- Disease‑modifying therapies
Approach seeks to preserve thinking skills and daily independence.
Narcolepsy with Cataplexy
Studies include narcolepsy with cataplexy (type 1) addressing excessive daytime sleepiness and sudden muscle weakness.
- Wake‑promoting pharmacology
- Cataplexy control mechanisms
- Sleep architecture monitoring
Research aims to improve alertness and reduce cataplectic episodes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.